Monitor for the company's hearing request filing by April 14, 2026. Absent a successful appeal or immediate reverse split, delisting is likely, which would trigger significant sell pressure and liquidity challenges. Consider exposure to micro-cap biotech stocks with Nasdaq compliance risks.
Price Chart
Executive Summary
Beyond Air, Inc. (XAIR) received a delisting notice from Nasdaq for failing to maintain a $1.00 minimum bid price for 30 consecutive business days. The company is ineligible for a standard 180-day cure period due to a prior reverse stock split in July 2025 and must request a hearing by April 14, 2026, to appeal the delisting. Trading will continue pending the hearing decision.
Key Facts
- Company: Beyond Air, Inc. (XAIR)
- Ticker: XAIR
- Exchange: Nasdaq
- Delisting Reason: Failure to meet $1.00 minimum bid price requirement (Nasdaq Listing Rule 5550(a)(2))
- Deficiency Period: 30 consecutive business days from February 23, 2026, to April 6, 2026
- No Cure Period: Company is ineligible for the standard 180-calendar-day compliance period due to a 1-for-20 reverse stock split executed on July 14, 2025
- Hearing Deadline: Must request a hearing by April 14, 2026, to appeal delisting
- Trading Status: Shares will continue to trade on Nasdaq pending the Nasdaq Hearings Panel's decision
- Market Cap: $9M
Financial Impact
High risk of delisting due to lack of compliance period and small market cap; potential loss of institutional investor base and reduced liquidity.
Risk Factors
- Delisting from Nasdaq, leading to reduced liquidity and potential exclusion from institutional indexes
- Inability to regain compliance due to ineligibility for a standard cure period
- Negative market perception and potential share price decline ahead of the hearing decision
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001493152-26-016172 |
| Document: 0001493152-26-016172-index-headers.html | 0001493152-26-016172 |
| Document: 0001493152-26-016172-index.html | 0001493152-26-016172 |
| Document: 0001493152-26-016172.txt | 0001493152-26-016172 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 21, 2026 5d ago | SC 13G/A | $2.34 | awaiting T+60 | — | $2.14 (−8.55%) |
Oct 8, 2026 18d ago | 8-K | $2.31 | awaiting T+60 | — | $2.14 (−7.36%) |
Sep 24, 2026 4w ago | 8-K | $2.85 | awaiting T+60 | — | $2.14 (−24.91%) |
Aug 25, 2026 8w ago | EFFECT | $4.98 | awaiting T+60 | — | $2.14 (+57.03%) |
Jul 31, 2026 12w ago | Insider Cluster | $6.33 | awaiting T+60 | — | $2.14 (−66.19%) |
Jul 31, 2026 12w ago | 8-K | $5.28 | awaiting T+60 | — | $2.14 (+59.43%) |
Jul 2, 2026 16w ago | Court Ruling | $0.4390 $0.1415 | ▲ +67.77% | ▲ +69.49% | $2.14 (−387.47%) |
Jun 26, 2026 17w ago | 8-K | $0.4646 $0.1505 | ▼ −67.61% | ▼ −71.22% | $2.14 (+360.61%) |
Jun 22, 2026 18w ago | 8-K | $0.4680 $0.1540 | ▼ −67.09% | ▼ −71.05% | $2.14 (+357.26%) |
Apr 20, 2026 27w ago | Press Release | $10.90 $5.55 | ▼ −49.08% | ▼ −55.28% | $2.14 (−80.37%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers